Please login to the form below

Not currently logged in
Email:
Password:

Teva's Mark Salyer joins Amarin

Takes up newly-created chief commercial officer role

Amarin has appointed Mark Salyer to the newly-created position of chief commercial officer.

He joins the Irish biopharma company from Teva, where he served as general manager of its US respiratory division, and prior to that he held senior roles at GlaxSmithKline and Altana.

Amarin’s president and CEO John Thero said: "Mark brings a strong track record of success coupled with valuable experience and proven leadership to our management team to help drive our anticipated expansion.

"We expect Mark's driven, people-oriented, hands-on approach to work well with our existing commercial organisation to help build on our growth.”

Salyer’s appointment comes at a key juncture for Amarin as it awaits next year’s publication of results from the REDUCE-IT cardiovascular outcomes trial. The 8,000-patient study involves its first FDA-approved product, the omega-3 fatty acid-based Vascepa.

21st September 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...

Infographics